Workplace accidents and injuries cost $136 billion annually. Among the major causes of impairment are drugs, alcohol, or fatigue. The legalization of recreational Cannabis has had an impact. Accident and injury rates with positive Cannabis testing have increased sharply. Because drugs like Cannabis and others remain in the body long after use, urine, and saliva tests typically reveal the presence of the drug, but not tell whether a person is impaired at the time of the test. That is why ZXEREX impairment screening is needed.

ZXEREX has developed the world’s first science-based impairment detection technology enhanced with AI and machine learning in studies conducted at major research institutions to deliver rapid, accurate, low-cost, non-invasive Impairment screening.

ZXEREX-Safe™ and Impair-ID powered by ZXEREX™ identify the effects of drugs on the brain by detecting temporary neurologic impairment. ZXEREX screens for temporary changes in the brain of a person who is impaired.  The technology detects impairment by looking for the effects of drugs rather than the drug’s presence in in the body and works in those whose metabolites remain positive on drug testing long after a person is no longer impaired. 

ZXEREX screening is non-invasive, cost-effective, and fast (2-3 minutes) and can be scheduled to maximize risk mitigation. 

ZXEREX screening when combined with a company’s safety program, helps to deter risky behavior such as showing up to work impaired or using while on the job.